American Century Multisector Income ETF MUSI 深 滬
等待開盤 10-31 09:30:00 美东时间
44.3954
-0.075
-0.17%
華盛通- 最 高44.4299
- 今 開44.39
- 成交量 5089股
- 最 低 44.3743
- 昨 收 44.47
- 總市值 1.80亿
- 52周最高 44.6199
- 市盈率 靜 --
- 換手率 0.13%
- 52周最低 40.4843
- 委 比 0.00%
- 總股本 405.00万
- 歷史最高 44.5172
- 量 比 0.40
- 振 幅 0.13%
- 歷史最低 34.4752
- 每 手 1
- 風險率 1.05%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多KKR buys South Korean cosmetics packaging firm Samhwa for $528M
Samhwa, a South Korean cosmetics packaging firm, has completed its sale to global investment firm KKR (NYSE:KKR), in a deal valued at KRW733 billion (around US$528 million). KKR has fully acquired the...
09-04 15:43
大和：升安踏体育目标价至117港元 上半年盈利胜预期
大和发布研报称，安踏体育（02020）上半年收入及净利润分别较市场预期高1.5%与3.2%，Descente与KolonSport的增长势头好过预期。该行将...
08-29 18:32
中金：维持安踏体育跑赢行业评级 目标价120.92港元
中金发布研报称，基本维持安踏体育（02020）2025/26年EPS预测4.82/5.47元，当前股价对应19/17倍2025/26年市盈率，维持跑赢行业评...
08-28 13:02
安踏体育(02020.HK)与MUSINSA成立合资公司共同营运韩国时装业务
【财华社讯】安踏体育(02020.HK)公布，公司附属公司(“安踏”)已与MUSINSA Co.,Ltd.订立一份合资协议。根据该合资协议，安踏与MUSINS...
08-27 13:37
Medera And University Of Kansas Medical Center Announce Treatment Of First Patient In MUSIC-DMD Phase 1b Clinical Trial For Duchenne Muscular Dystrophy
Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, and its clinical development division Sardocor, together with
07-15 20:11
Medera Showcases Interim Data From First-in-Human Gene Therapy Trial For HFpEF In Late-Breaking Presentation At Heart Failure 2025 Congress; Clinical Trial Show Favorable Safety Profile And Early Clinical Benefits With SRD-002 Gene Therapy
Results from MUSIC-HFpEF Phase 1/2a clinical trial show favorable safety profile and early clinical benefits with SRD-002 gene therapyBOSTON, May 19, 2025 (GLOBE NEWSWIRE) -- Medera Inc. ("Medera"), a clinical-stage
05-19 20:06
